Melatonin supplementation, hyperprolactinemia, and incident heart failure: A proposed prolactin-mediated pathway for cardiovascular risk
World Journal of Experimental Medicine · 10.06.2026
DOI: 10.5493/wjem.120754 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Experimental Medicine, online erschienen am 10.06.2026. Verfasst von Christos Savvidis und 2 weiteren Autor:innen.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Savvidis, C., Thomopoulos, C., & Ilias, I. (2026). Melatonin supplementation, hyperprolactinemia, and incident heart failure: A proposed prolactin-mediated pathway for cardiovascular risk. World Journal of Experimental Medicine. https://doi.org/10.5493/wjem.120754
Vancouver
Savvidis C, Thomopoulos C, Ilias I. Melatonin supplementation, hyperprolactinemia, and incident heart failure: A proposed prolactin-mediated pathway for cardiovascular risk. World Journal of Experimental Medicine. 2026. doi:10.5493/wjem.120754
BibTeX
@article{Savvidis2026,
author = {Savvidis, Christos and Thomopoulos, Costas and Ilias, Ioannis},
title = {Melatonin supplementation, hyperprolactinemia, and incident heart failure: A proposed prolactin-mediated pathway for cardiovascular risk},
journal = {World Journal of Experimental Medicine},
year = {2026},
doi = {10.5493/wjem.120754}
}
EUVIMED